approval
saveJUBBONTI (DENOSUMAB-BBDZ) — FDA approval
community read0 votes
Sponsor: SANDOZ INC. Form: INJECTABLE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 2
same company · ±60 days · 6
- approvalnatalizumab biosimilar: TYRUKO (NATALIZUMAB-SZTN) — FDA approvalOct 30, 2025
- approvalDIFLUPREDNATE: DUREZOL (DIFLUPREDNATE) — FDA approvalOct 27, 2025
- approvalANASTROZOLE: ANASTROZOLE — FDA approvalOct 24, 2025
- approvalBUPROPION HYDROCHLORIDE: BUPROPION HYDROCHLORIDE — FDA approvalNov 6, 2025
- approvalHYRIMOZ: HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalOct 16, 2025
- approvalONDANSETRON — FDA approvalNov 13, 2025
comments(0)
5-min edit window · permanent after that